Aural Manifestations of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis—Diagnosis, Symptoms, Treatment

• Published in: Journal of clinical medicine Vol. 13; no. 15; p. 4298
• Main Authors: Kaczmarczyk, Michał S., Jurkiewicz, Dariusz, Niemczyk, Stanisław, Rymarz, Aleksandra
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.08.2024
• Subjects: Antibodies; Asymptomatic; Autoantibodies; Care and treatment; Diagnosis; Ear diseases; Ears & hearing; Health aspects; Hearing loss; Inflammation; Internal medicine; Medical research; Medicine, Experimental; Otolaryngology; Physiological aspects; Vasculitis; Poland; facial palsy; ANCA; OMAAV; hypertrophic pachymeningitis; BVAS; VDI; aural manifestation
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm13154298

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of vasculitis sharing a common pathophysiology, which affects small and medium blood vessels. There are three categories of AAV: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA). As a systemic disease, AAV can affect basically every organ. The goal of this publication is to sum up and underline the problem of the aural manifestation of AAV; it details the definition of Otitis Media with Antineutrophil Cytoplasmic Antibody Associated Vasculitis (OMAAV) and allows for a better understanding of the specific tasks of medical professionals taking part in the diagnostic and therapeutic process. Among others, this publication is directed to otolaryngologists who may encounter patients with AAV and often are the first specialists who see patients with early symptoms of AAV. This publication presents brief characteristics of AAV, descriptions of aural manifestations and symptoms, differential diagnosis, and both pharmacological and surgical treatment options, based on current recommendations and information found in the literature and clinical databases.